Auxier Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Buy
599
+20
+3% +$20.4K 0.1% 122
2026
Q1
$533K Buy
579
+16
+3% +$16.2K 0.08% 131
2025
Q4
$605K Sell
563
-50
-8% -$47.8K 0.09% 126
2025
Q3
$468K Sell
613
-1
-0.2% -$744 0.07% 129
2025
Q2
$479K Sell
614
-1
-0.2% -$777 0.07% 128
2025
Q1
$508K Sell
615
-12
-2% -$9.98K 0.08% 124
2024
Q4
$484K Hold
627
0.08% 124
2024
Q3
$555K Sell
627
-42
-6% -$37.8K 0.08% 123
2024
Q2
$606K Sell
669
-31
-4% -$24.8K 0.1% 120
2024
Q1
$545K Sell
700
-11
-2% -$7.83K 0.08% 124
2023
Q4
$414K Sell
711
-25
-3% -$14.6K 0.07% 133
2023
Q3
$395K Buy
736
+10
+1% +$5.15K 0.07% 125
2023
Q2
$340K Hold
726
0.06% 137
2023
Q1
$249K Hold
726
0.04% 144
2022
Q4
$266K Hold
726
0.05% 141
2022
Q3
$235K Hold
726
0.05% 141
2022
Q2
$235K Hold
726
0.04% 148
2022
Q1
$208K Hold
726
0.03% 160
2021
Q4
$201K Buy
+726
New +$184K 0.03% 166

Other funds holding LLY

Auxier Asset Management's LLY Position: Q2 2026 in Review

Auxier Asset Management increased its Eli Lilly (LLY) stake by 3.5% in Q2 2026, buying an estimated $20.4K and bringing the position to 599 shares worth $718K. The position accounts for 0.1% of the portfolio, ranked #122.

Auxier Asset Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Auxier Asset Management held 599 shares of Eli Lilly worth $718K as of Q2 2026.
  • Auxier Asset Management bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.1% of Auxier Asset Management's portfolio in Q2 2026, its #122 holding.
  • Auxier Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Auxier Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.